|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Multitemporal Fuzzy Classification Model based on Class Transition Possibil- ities显示文摘 | Mota G L Feitosa R Q Coutinho H L | 2007 | ISPRS Journal of Photogrammetry and Remote Sens- ing2007，62，3： | 1 |
| 2 | Efeito da pimenta rosa assoeiada a diversas dosagens de antibioticos em frangos de eorte显示文摘 | Gonealves F G Zanini S F Feitosa S F | 2012 | Cieneia Rural2012，，8： | 1 |
| 3 | Chemical composition and larvicidal activity of Rollinia leptopetala (Annonaceae) 显示文摘 | Feitosa E M A Arriaga A M C Santiago G M P | 2009 | J BrazChemSoc2009，20，2： | 1 |
| 4 | High Prevalence of giardiasis and Strongyloidias among HIV-infected Patients in Bahia,Brazil显示文摘 | Feitosa G Bandeira AC SamPaio DP | 2001 | Braz J Infec Dis2001，5，6： | 1 |
| 5 | High Prevalence of giardiasis and Strongyloidiasamong HIV-infected Patients in Bahia,Brazil显示文摘 | Feitosa G Bandeira AC SamPaioDP | 2001 | Brazilian Journal of Infectious Disease2001，5，： | 1 |
| 6 | Multi-agent simulator for urban segre- gation (MASUS): A tool to explore alternatives for promoting inclusive cities显示文摘 | FEITOSA F LE Q B VLEK P L G | 2011 | Computers environment and urban systems2011，35，2： | 1 |
| 7 | Stroke awareness in Brazil:alarming results in a community-based study显示文摘 | Pontes-Neto O M Silva G S Feitosa M R | | 0，，02： | 1 |
| 8 | High prevalence of Giardiasis and stron- lyloidiasis among HIV-inSeeted patients in Brazil显示文摘 | Feitosa G Baneira AC | 2001 | Braa J In- fect Dis2001，5，1： | 1 |
| 9 | High prevalence of giardiasis and stronlyloidiasis among HIV-infected patients in Brazil Braz显示文摘 | FEITOSA G BANEIRA AC | 2001 | J Infect Dis2001，5，： | 1 |
| 10 | High prevalence of giardiasis and strongyloidiasis among HIV-infected patients in Bahia, Brazil 显示文摘 | Feitosa G Bandeira AC Sampaio DP | 2001 | Braz J Infect Dis2001，5，： | 1 |
| 11 | Multitemporal fuzzy classification model based on class tran sition possibilities显示文摘 | MOTA G L A FEITOSA R Q COUTINHO H L C | 2007 | ISPRS Journal of Photogramrnetry and Remote Sensing2007，62，3： | 1 |
| 12 | Multi-Agent Simulator for Urban Segregation (MASUS): A Tool to Explore Alternatives for Promoting inclusive Cities显示文摘 | FEITOSA F F LE q B VIEK P L G | 2011 | Computers Environment and Urban Systems2011，35，2： | 1 |
| 13 | Structural Organization of Cetyltrimethylammonium Sulfate in Aqueous Solution: The Effect of Na2S04显示文摘 | Feitosa E Brazolin M R S Naal R M Z G | 2006 | J Colloid ltuerface Sci2006，299，2： | 1 |
| 14 | Real-world treatment patterns and disease control over one year in patients with inflammatory bowel disease in Brazil显示文摘BACKGROUND Crohn’s disease(CD)and ulcerative colitis(UC)are inflammatory bowel diseases(IBDs)with a remission-relapsing presentation and symptomatic exacerbations that have detrimental impacts on patient quality of life and are associated with a high cost burden,especially in patients with moderate-to-severe disease.The Real-world Data of Moderate-to-Severe Inflammatory Bowel Disease in Brazil(RISE BR)study was a noninterventional study designed to evaluate disease control,treatment patterns,disease burden and health-related quality of life in patients with moderate-to-severe active IBD.We report findings from the prospective follow-up phase of the RISE BR study in patients with active UC or CD.AIM To describe the 12-mo disease evolution and treatment patterns among patients with active moderate-to-severe IBD in Brazil.METHODS This was a prospective,noninterventional study of adult patients with active Crohn’s disease(CD:Harvey-Bradshaw Index≥8,CD Activity Index≥220),inadequate CD control(i.e.,calprotectin>200μg/g or colonoscopy previous results),or active ulcerative colitis(UC:Partial Mayo score≥5).Enrollment occurred in 14 centers from October 2016 to February 2017.The proportion of active IBD patients after 9-12 mo of follow-up,Kaplan-Meier estimates of the time to mild or no activity and a summary of treatment initiation,discontinuation and dose changes were examined.RESULTS The study included 118 CD and 36 UC patients,with mean±SD ages of 43.3±12.6 and 44.9±16.5 years,respectively.The most frequent drug classes at index were biologics for CD(62.7%)and 5-aminosalicylate derivates for UC patients(91.7%).During follow-up,65.3%of CD and 86.1%of UC patients initiated a new treatment at least once.Discontinuations/dose changes occurred in 68.1%of CD patients[median 2.0(IQR:2-5)]and 94.3%of UC patients[median 4.0(IQR:3-7)].On average,CD and UC patients had 4.4±2.6 and 5.0±3.3 outpatient visits,respectively.The median time to first mild or no activity was 319(IQR:239-358)d for CD and 320(IQR:288-358)d for UC patients.At 9-12 mo,22.0%of CD and 20.0%of UC patients had active disease.CONCLUSION Although a marked proportion of active IBD patients achieved disease control within one year,the considerable time to achieve this outcome represents an unmet medical need of the current standard of care in a Brazilian real-world setting. | Ligia Yukie Sassaki Sender J Miszputen Roberto Luiz Kaiser Junior Wilson R Catapani Mauro Bafutto António S Scotton Cyrla Zaltman Julio Pinheiro Baima Hagata S Ramos Mikaell Alexandre Gouvea Faria Carolina D Gonçalves Isabella Miranda Guimaraes Cristina Flores Heda M B S Amarante Rodrigo Bremer Nones JoséMiguel Luz Parente Murilo Moura Lima Júlio Maria Chebli Maria de Lourdes Abreu Ferrari Julia F Campos Maria G P Sanna Odery Ramos Rogério Serafim Parra Jose J R da Rocha Omar Feres Marley R Feitosa Rosana Fusaro Caratin Juliana Tosta Senra Genoile Oliveira Santana | 2021 | World Journal of Gastroenterology2021，27，23： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员